Last reviewed · How we verify
NCT05116280
MACE and PE in Elective Primary TKA & THA
trial in Cardiovascular Complication in 200 participants. Completed in 30 January 2019.
31 December 2018
Quick facts
| Lead sponsor | University of Thessaly |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 January 2018 |
| Primary completion | 31 December 2018 |
| Estimated completion | 30 January 2019 |
| Sites | 1 location across Greece |
Conditions studied
- Cardiovascular Complication — all drugs for Cardiovascular Complication →
- Pulmonary Embolism — all drugs for Pulmonary Embolism →
- Stroke — all drugs for Stroke →
- Transient Ischemic Attack — all drugs for Transient Ischemic Attack →
Sponsor
University of Thessaly
Who can join
Eligibility, any sex, with Cardiovascular Complication or Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study ought to identify the occurence of the major adverse cardiovascular events (MACE) and the pumonary emoblism (PE) in patients undergoing elective primary THA \& TKA
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05116280
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Complication
Currently open trials in the same condition.
- NCT06279000 — Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery · Phase 3 · recruiting
- NCT06902857 — Study on the Predictive Value of High-sensitivity Cardiac Troponin I, N-terminal Pro-B-natriuretic Peptide, and Soluble · recruiting
- NCT06358079 — Re-infusion of Unwashed Shed Blood During Off-pump Surgery · NA · active not recruiting
- NCT06826534 — At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure · NA · recruiting
- NCT05679024 — Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation · Phase 3 · recruiting
Other University of Thessaly trials
Trials by the same sponsor.
- NCT07376187 — Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases · NA · not yet recruiting
- NCT07496151 — The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. · NA · not yet recruiting
- NCT07420309 — Colonoscopy TRaining With or Without Artificial INtelligence Among Endoscopy Residents · NA · recruiting
- NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
- NCT07380009 — Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Rece · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05116280 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Thessaly
- Last refreshed: 11 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05116280.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing